MyAverix Finance
F · Healthcare
NANEXA AB (40M)
Drug Manufacturers - Specialty & Generic
NANEXA AB (40M) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 40M
NANEXA AB (40M) — FAQ
What is 40M's P/E ratio?
The price-to-earnings (P/E) ratio for NANEXA AB (40M) is 18.00 (data as of 2026-03-24).
Does NANEXA AB pay a dividend?
Dividend yield is not available in the current snapshot for NANEXA AB (40M). Check the MyAverix Finance app for the latest dividend data.
What sector is NANEXA AB in?
NANEXA AB (40M) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 40M listed on?
40M is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.